311 related articles for article (PubMed ID: 24217610)
1. Angiogenesis in multiple myeloma.
Vacca A; Ria R; Reale A; Ribatti D
Chem Immunol Allergy; 2014; 99():180-96. PubMed ID: 24217610
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow angiogenesis in multiple myeloma.
Vacca A; Ribatti D
Leukemia; 2006 Feb; 20(2):193-9. PubMed ID: 16357836
[TBL] [Abstract][Full Text] [Related]
3. Mast cells contribute to vasculogenic mimicry in multiple myeloma.
Nico B; Mangieri D; Crivellato E; Vacca A; Ribatti D
Stem Cells Dev; 2008 Feb; 17(1):19-22. PubMed ID: 18205547
[TBL] [Abstract][Full Text] [Related]
4. New Insights in Anti-Angiogenesis in Multiple Myeloma.
Ribatti D; Vacca A
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30002349
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in multiple myeloma.
Jakob C; Sterz J; Zavrski I; Heider U; Kleeberg L; Fleissner C; Kaiser M; Sezer O
Eur J Cancer; 2006 Jul; 42(11):1581-90. PubMed ID: 16797965
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and vasculogenesis in multiple myeloma: role of inflammatory cells.
Vacca A; Ribatti D
Recent Results Cancer Res; 2011; 183():87-95. PubMed ID: 21509681
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic activity of mesenchymal stem cells in multiple myeloma.
Wang X; Zhang Z; Yao C
Cancer Invest; 2011 Jan; 29(1):37-41. PubMed ID: 21166497
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.
De Luisi A; Binetti L; Ria R; Ruggieri S; Berardi S; Catacchio I; Racanelli V; Pavone V; Rossini B; Vacca A; Ribatti D
Angiogenesis; 2013 Oct; 16(4):963-73. PubMed ID: 23881169
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis.
Ribatti D; Nico B; Vacca A
Int Rev Cell Mol Biol; 2015; 314():259-82. PubMed ID: 25619720
[TBL] [Abstract][Full Text] [Related]
10. Role of tumour angiogenesis in haematological malignancies.
Medinger M; Passweg J
Swiss Med Wkly; 2014; 144():w14050. PubMed ID: 25375891
[TBL] [Abstract][Full Text] [Related]
11. Biological aspects of angiogenesis in multiple myeloma.
Otjacques E; Binsfeld M; Noel A; Beguin Y; Cataldo D; Caers J
Int J Hematol; 2011 Dec; 94(6):505-18. PubMed ID: 22086206
[TBL] [Abstract][Full Text] [Related]
12. Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.
Lamanuzzi A; Saltarella I; Ferrucci A; Ria R; Ruggieri S; Racanelli V; Rao L; Annese T; Nico B; Vacca A; Ribatti D
Oncotarget; 2016 Mar; 7(12):14510-21. PubMed ID: 26919105
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis.
Andersen NF; Kristensen IB; Preiss BS; Christensen JH; Abildgaard N
Eur J Haematol; 2015 Sep; 95(3):211-7. PubMed ID: 25353275
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment.
Klein B; Seckinger A; Moehler T; Hose D
Recent Results Cancer Res; 2011; 183():39-86. PubMed ID: 21509680
[TBL] [Abstract][Full Text] [Related]
15. Exosome-derived miR-let-7c promotes angiogenesis in multiple myeloma by polarizing M2 macrophages in the bone marrow microenvironment.
Tian X; Sun M; Wu H; Chen C; Li H; Qiu S; Wang T; Han J; Xiao Q; Chen K
Leuk Res; 2021 Jun; 105():106566. PubMed ID: 33848709
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic switch in multiple myeloma.
Giuliani N; Colla S; Rizzoli V
Hematology; 2004; 9(5-6):377-81. PubMed ID: 15763977
[TBL] [Abstract][Full Text] [Related]
17. Mast Cells and Angiogenesis in Human Plasma Cell Malignancies.
Ribatti D; Tamma R; Vacca A
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678047
[TBL] [Abstract][Full Text] [Related]
18. [Link between osteoclastogenesis, angiogenesis and myeloma expansion].
Abe M
Clin Calcium; 2008 Apr; 18(4):473-9. PubMed ID: 18379029
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow microvascular density and angiogenic growth factors in multiple myeloma.
Alexandrakis MG; Passam FJ; Ganotakis E; Dafnis E; Dambaki C; Konsolas J; Kyriakou DS; Stathopoulos E
Clin Chem Lab Med; 2004; 42(10):1122-6. PubMed ID: 15552270
[TBL] [Abstract][Full Text] [Related]
20. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
Basile A; Moschetta M; Ditonno P; Ria R; Marech I; De Luisi A; Berardi S; Frassanito MA; Angelucci E; Derudas D; Specchia G; Curci P; Pavone V; Rossini B; Ribatti D; Bottazzi B; Mantovani A; Presta M; Dammacco F; Vacca A
J Pathol; 2013 Jan; 229(1):87-98. PubMed ID: 22847671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
